Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Org Biomol Chem ; 16(1): 48-52, 2017 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-29215120

RESUMEN

DNA encoded ligands are self-assembled into bivalent complexes and chemically ligated to link their identities. To demonstrate their potential as a combinatorial screening platform for avidity interactions, the optimal bivalent aptamer design (examplar ligands) for human alpha-thrombin is determined in a single round of selection and the DNA scaffold replaced with minimal impact on the final design.


Asunto(s)
Técnicas Químicas Combinatorias , ADN/química , Bibliotecas de Moléculas Pequeñas/química , Trombina/análisis , Cristalografía por Rayos X , Humanos , Ligandos , Modelos Moleculares , Estructura Molecular
2.
Anal Chem ; 85(12): 5950-7, 2013 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-23672295

RESUMEN

Aptamer microarrays are a promising high-throughput method for ultrasensitive detection of multiple analytes, but although much is known about the optimal synthesis of oligonucleotide microarrays used in hybridization-based genomics applications, the bioaffinity interactions between aptamers and their targets is qualitatively different and requires significant changes to synthesis parameters. Focusing on streptavidin-binding DNA aptamers, we employed light-directed in situ synthesis of microarrays to analyze the effects of sequence fidelity, linker length, surface probe density, and substrate functionalization on detection sensitivity. Direct comparison with oligonucleotide hybridization experiments indicates that aptamer microarrays are significantly more sensitive to sequence fidelity and substrate functionalization and have different optimal linker length and surface probe density requirements. Whereas microarray hybridization probes generate maximum signal with multiple deletions, aptamer sequences with the same deletion rate result in a 3-fold binding signal reduction compared with the same sequences synthesized for maximized sequence fidelity. The highest hybridization signal was obtained with dT 5mer linkers, and the highest aptamer signal was obtained with dT 11mers, with shorter aptamer linkers significantly reducing the binding signal. The probe hybridization signal was found to be more sensitive to molecular crowding, whereas the aptamer probe signal does not appear to be constrained within the density of functional surface groups commonly used to synthesize microarrays.


Asunto(s)
Aptámeros de Nucleótidos/biosíntesis , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Estimulación Luminosa/métodos , Aptámeros de Nucleótidos/genética , Unión Proteica/fisiología
3.
Proc Natl Acad Sci U S A ; 105(20): 7275-80, 2008 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-18480264

RESUMEN

The protein tyrosine phosphatase Shp2 is a positive regulator of growth factor signaling. Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene. We performed a high-throughput in silico screen for small-molecular-weight compounds that bind the catalytic site of Shp2. We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1B. PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis. PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin. Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-associated Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines. The PHPS compound class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.


Asunto(s)
Bencenosulfonatos/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Regulación de la Expresión Génica , Hidrazonas/farmacología , Proteína Tirosina Fosfatasa no Receptora Tipo 11/fisiología , Animales , Bencenosulfonatos/química , Dominio Catalítico , Perros , Factor de Crecimiento de Hepatocito/metabolismo , Humanos , Hidrazonas/química , Cinética , Leucemia/metabolismo , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Modelos Biológicos , Proteína Tirosina Fosfatasa no Receptora Tipo 11/metabolismo , Pirazolonas/química , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA